{"id":36922,"date":"2026-06-03T20:00:57","date_gmt":"2026-06-03T14:30:57","guid":{"rendered":"https:\/\/atsixty.com\/?p=36922"},"modified":"2026-06-03T20:01:36","modified_gmt":"2026-06-03T14:31:36","slug":"pancreatic-diseases","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/","title":{"rendered":"Pancreatic Diseases"},"content":{"rendered":"\n\n\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&#038;family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&#038;display=swap\" rel=\"stylesheet\">\n<style>\n\/* ============================================================\n   Morning Rounds \u00b7 GIT Quiz 05 \u00b7 Pancreatic Diseases\n   Namespace: #git05\n   Palette: deep teal-green (GIT series standard)\n   Template: git04 \u2014 plain diff label, exp + Extra Points\n   ============================================================ *\/\n\n#git05 *,#git05 *::before,#git05 *::after{box-sizing:border-box;margin:0;padding:0}\n\n#git05{\n  --ter:#1A6B5A;\n  --ter-light:#2A8C77;\n  --ter-pale:#EBF6F3;\n  --ter-dark:#125048;\n  --correct:#2D6B47;\n  --correct-bg:#EAF6EF;\n  --correct-border:#3A9960;\n  --wrong:#B83232;\n  --wrong-bg:#FDF0F0;\n  --wrong-border:#E53935;\n  --ink:#1C2E2A;\n  --ink-mid:#3D5A54;\n  --ink-soft:#7A9A94;\n  --line:#D8E8E5;\n  --cream:#F5FAF9;\n  --warm:#FDFFFE;\n\n  font-family:'Source Serif 4',Georgia,serif;\n  font-size:16px;color:var(--ink);background:var(--cream);\n  line-height:1.7;padding:0 0 64px;\n}\n\n#git05 .mr-header{background:var(--ter);color:#FDFFFE;padding:34px 24px 28px;text-align:center}\n#git05 .mr-eyebrow{font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;font-weight:600;opacity:0.65;margin-bottom:10px}\n#git05 .mr-title{font-family:'Playfair Display',serif;font-size:1.75rem;font-weight:700;line-height:1.2;margin-bottom:4px}\n#git05 .mr-title em{font-style:italic;font-weight:400;opacity:0.88}\n#git05 .mr-subtitle{font-size:0.82rem;opacity:0.7;margin-top:8px;font-style:italic}\n#git05 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap}\n#git05 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.73rem}\n\n#git05 .mr-sentinel{height:1px}\n#git05 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(26,107,90,0.10);padding:9px 16px;display:none}\n#git05 .mr-progress.visible{display:block}\n#git05 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#git05 .mr-pips{display:flex;align-items:center;justify-content:center}\n#git05 .mr-pip-wrap{display:flex;align-items:center}\n#git05 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#git05 .mr-pip-line.done{background:var(--ter)}\n#git05 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0}\n#git05 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#git05 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n\n#git05 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#git05 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ter);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 6px rgba(26,107,90,0.06)}\n#git05 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#git05 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ter);opacity:0.16;line-height:1;margin-top:-2px;flex-shrink:0}\n#git05 .mr-meta{flex:1}\n#git05 .mr-tag-row{display:flex;align-items:center;justify-content:space-between;margin-bottom:5px}\n#git05 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ter);opacity:0.8}\n#git05 .mr-diff{font-size:0.61rem;font-weight:700;letter-spacing:0.10em;text-transform:uppercase;color:var(--ink-soft)}\n#git05 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#git05 .mr-stem strong{font-weight:600}\n#git05 .mr-stem em{font-style:italic}\n#git05 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n\n#git05 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#git05 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent}\n#git05 .mr-opt:hover{border-color:var(--ter);background:var(--ter-pale)}\n#git05 .mr-opt.locked{cursor:default}\n#git05 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#git05 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#git05 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#git05 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#git05 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#git05 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#git05 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#git05 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s}\n#git05 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#git05 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#git05 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#git05 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#git05 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n\n#git05 .mr-exp{display:none;border-top:1px solid #b8ddd6;background:linear-gradient(180deg,#e8f5f2 0%,#f2faf8 100%);padding:13px 20px 15px}\n#git05 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:var(--correct);margin-bottom:6px}\n#git05 .mr-exp-text{font-size:0.86rem;color:#1c4a3a;line-height:1.68}\n#git05 .mr-exp-text strong{font-weight:600}\n#git05 .mr-exp-text em{font-style:italic}\n#git05 .mr-exp-extra{margin-top:11px;padding-top:10px;border-top:1px dashed #9ACCC4;font-size:0.84rem;color:#1c4a3a;line-height:1.66}\n#git05 .mr-exp-extra-lbl{font-size:0.59rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:var(--ter);margin-bottom:4px;display:block}\n#git05 .mr-exp-extra strong{font-weight:600}\n#git05 .mr-exp-extra em{font-style:italic}\n\n#git05 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#git05 .mr-btn{background:var(--ter);color:#FDFFFE;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 8px rgba(26,107,90,0.30)}\n#git05 .mr-btn:hover{background:var(--ter-dark)}\n#git05 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ter);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(26,107,90,0.10);overflow:hidden}\n#git05 .mr-score-in{padding:28px 24px;text-align:center}\n#git05 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600}\n#git05 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ter) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative}\n#git05 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm)}\n#git05 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#git05 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ter)}\n#git05 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#git05 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#git05 .mr-score-net{font-size:0.9rem;color:var(--ter);font-weight:600;margin-bottom:4px}\n#git05 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#git05 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#git05 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#git05 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#git05 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#git05 .mr-band-s{background:var(--ter-pale);color:var(--ter)}\n#git05 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ter);color:var(--ter);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer}\n#git05 .mr-retry:hover{background:var(--ter);color:#FDFFFE}\n\n@media(max-width:480px){\n  #git05 .mr-title{font-size:1.4rem}\n  #git05 .mr-num{font-size:1.7rem}\n  #git05 .mr-stem{font-size:0.9rem}\n  #git05 .mr-opt-text{font-size:0.86rem}\n}\n<\/style>\n\n<div id=\"git05\">\n\n  <div class=\"mr-header\">\n    <div class=\"mr-eyebrow\">Morning Rounds &middot; GIT Series<\/div>\n    <div class=\"mr-title\">\n      Pancreatic Diseases<br><em>Gastroenterology<\/em>\n    <\/div>\n    <div class=\"mr-subtitle\">Five high-yield clinical cases &middot; +4 \/ &minus;1 scoring &middot; NEET-PG and UPSC CMS<\/div>\n    <div class=\"mr-chips\">\n      <span class=\"mr-chip\">5 Cases<\/span>\n      <span class=\"mr-chip\">+4 \/ &minus;1 scoring<\/span>\n      <span class=\"mr-chip\">Options reshuffled<\/span>\n    <\/div>\n  <\/div>\n\n  <div class=\"mr-sentinel\" id=\"git05-sentinel\"><\/div>\n\n  <div class=\"mr-progress\" id=\"git05-progress\">\n    <div class=\"mr-prog-inner\">\n      <div class=\"mr-pips\" id=\"git05-pips\"><\/div>\n    <\/div>\n  <\/div>\n\n  <div class=\"mr-body\">\n    <div id=\"git05-cases\"><\/div>\n    <div class=\"mr-submit-wrap\">\n      <button class=\"mr-btn\" id=\"git05-submit\">Submit for Debrief<\/button>\n    <\/div>\n    <div class=\"mr-score\" id=\"git05-score\">\n      <div class=\"mr-score-in\">\n        <div class=\"mr-score-ey\">Round Complete<\/div>\n        <div class=\"mr-ring\" id=\"git05-ring\">\n          <div class=\"mr-ring-in\">\n            <span class=\"mr-ring-pct\" id=\"git05-pct\">0%<\/span>\n            <span class=\"mr-ring-sub\">net<\/span>\n          <\/div>\n        <\/div>\n        <div class=\"mr-score-title\">Your Debrief<\/div>\n        <div class=\"mr-score-net\" id=\"git05-net\"><\/div>\n        <div class=\"mr-verdict\" id=\"git05-verdict\"><\/div>\n        <div class=\"mr-bands\">\n          <span class=\"mr-band mr-band-c\" id=\"git05-ct-c\"><\/span>\n          <span class=\"mr-band mr-band-w\" id=\"git05-ct-w\"><\/span>\n          <span class=\"mr-band mr-band-s\" id=\"git05-ct-s\"><\/span>\n        <\/div>\n        <button class=\"mr-retry\" id=\"git05-retry\">&#8635; New Round<\/button>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/div>\n\n<script>\n\/* ============================================================\n   Morning Rounds \u00b7 GIT Quiz 05 \u00b7 Pancreatic Diseases\n   Namespace : git05\n   TOTAL     : 5 questions  |  MAX : 20  |  +4 \/ \u22121\n   Shuffle   : Fisher-Yates on options each build()\n   Correct   : matched by answer TEXT\n   Debrief   : q.exp = main text; q.extra = Extra Points para\n   ============================================================ *\/\n(function () {\n  'use strict';\n\n  var NS    = 'git05';\n  var TOTAL = 5;\n  var MAX   = 20;\n  var LTRS  = ['A','B','C','D'];\n\n  \/* ================================================================\n     QUESTION BANK \u2014 Pancreatic Diseases\n     Topics: Acute pancreatitis (causes, Ranson's, Atlanta),\n             Complications of acute pancreatitis (necrosis, pseudocyst),\n             Chronic pancreatitis (tropical, alcohol),\n             Pancreatic carcinoma (head vs body\/tail),\n             Insulinoma \/ Zollinger-Ellison (endocrine tumours)\n\n     Q1  ACUTE PANCREATITIS \u2014 CAUSES & RANSON'S CRITERIA (Easy)\n         Causes: Gallstones (#1 overall), Alcohol (#2; #1 in men\n           in India), hypertriglyceridaemia, hypercalcaemia,\n           ERCP, drugs (azathioprine, thiazides, steroids,\n           valproate, tetracycline), trauma, scorpion sting\n           (India \u2014 Mesobuthus tamulus), mumps, idiopathic.\n         Mnemonic GET SMASHED.\n         Ranson's criteria (non-gallstone):\n           On admission: Age >55, WBC >16,000, glucose >200,\n             LDH >350, AST >250.\n           Within 48 hrs: Haematocrit fall >10%, BUN rise >5,\n             Ca\u00b2\u207a <8, PaO\u2082 <60, Base deficit >4, Fluid >6L.\n           Score \u22653 = severe; each point adds ~1% mortality.\n         Atlanta classification (2012 revised):\n           Mild: no organ failure, no local complications.\n           Moderately severe: transient OF (<48 hr) or local\n             complications without persistent OF.\n           Severe: persistent organ failure (>48 hr).\n         Management: aggressive IV fluid resuscitation (IVF)\n           is cornerstone; nothing by mouth initially; analgesia\n           (diclofenac\/tramadol \u2014 pethidine no longer preferred);\n           ERCP within 24\u201372 hr if gallstone pancreatitis +\n           cholangitis; antibiotics only if infected necrosis.\n         Answer: Gallstones #1 cause overall; Ranson \u22653 = severe;\n                 IVF is cornerstone; ERCP for gallstone + cholangitis.\n\n     Q2  COMPLICATIONS \u2014 PSEUDOCYST & NECROTISING PANCREATITIS (Medium)\n         Local complications:\n           Acute peripancreatic fluid collection (APFC): early,\n             no wall, resolves spontaneously in most.\n           Pancreatic pseudocyst: fluid collection with a\n             non-epithelialised fibrous wall; forms >4 weeks\n             after acute pancreatitis; persistent, round, on CT.\n             Rx: drain if symptomatic (endoscopic preferred),\n             most resolve spontaneously.\n           Acute necrotic collection (ANC): early necrosis.\n           Walled-off necrosis (WON): necrosis with wall >4 wk.\n           Infected necrosis: fever + gas on CT = infected;\n             IV meropenem\/imipenem; step-up approach\n             (percutaneous drain \u2192 endoscopic\/surgical\n             necrosectomy); minimally invasive preferred.\n         Grey Turner's sign: flank bruising (retroperitoneal\n           haemorrhage).\n         Cullen's sign: periumbilical bruising.\n         Both = severe haemorrhagic pancreatitis; poor prognosis.\n         Systemic: ARDS, AKI, DIC, hypocalcaemia (fat saponification\n           \u2192 calcium binds free fatty acids \u2192 \u2193serum Ca\u00b2\u207a).\n         Answer: Pseudocyst = fibrous wall, >4 wk, no epithelium;\n                 Grey Turner + Cullen = haemorrhagic pancreatitis;\n                 hypocalcaemia from saponification.\n\n     Q3  CHRONIC PANCREATITIS \u2014 TROPICAL & ALCOHOLIC (Medium)\n         Causes: Alcohol (#1 in most countries), tropical\n           (fibrocalculous \u2014 India, Africa, SE Asia; young,\n           non-alcoholic, nutritional), hereditary (PRSS1,\n           SPINK1 mutations), autoimmune, idiopathic.\n         Tropical pancreatitis (fibrocalculous pancreatic\n           diabetes \u2014 FCPD): young patient, malnutrition,\n           LARGE intraductal calculi on X-ray\/CT, exocrine\n           insufficiency, brittle diabetes (ketosis-resistant \u2014\n           some residual glucagon). Unique to India.\n         Features: recurrent abdominal pain, steatorrhoea\n           (exocrine insufficiency \u2014 faecal elastase \u2193),\n           diabetes mellitus (endocrine insufficiency).\n         Investigations: plain X-ray abdomen (calcifications),\n           CT (gold standard for ductal changes + calculi),\n           MRCP, secretin-stimulated MRCP.\n         ERCP + stenting for ductal strictures;\n           Puestow procedure (lateral pancreaticojejunostomy)\n           for dilated duct.\n         Pancreatic enzyme replacement (PERT) for steatorrhoea.\n         Answer: FCPD \u2014 young, tropical, large calculi,\n                 ketosis-resistant diabetes; steatorrhoea =\n                 exocrine insufficiency; PERT treatment.\n\n     Q4  CARCINOMA OF PANCREAS \u2014 HEAD vs BODY\/TAIL (Hard)\n         ~95% ductal adenocarcinoma; very poor prognosis\n           (5-yr survival ~10\u201312% overall; <5% if unresectable).\n         Most common site: head of pancreas (60\u201370%).\n         Risk factors: smoking (#1 modifiable), chronic\n           pancreatitis, diabetes, obesity, BRCA2, hereditary\n           pancreatitis (PRSS1), Lynch syndrome, age >60.\n         Head of pancreas:\n           Presents early with obstructive jaundice (painless\n           progressive jaundice \u2014 Courvoisier's law: palpable,\n           non-tender gallbladder + jaundice = unlikely stones,\n           likely malignancy).\n           Weight loss, pale stools, dark urine.\n           Stent or Whipple's (pancreaticoduodenectomy).\n         Body\/tail of pancreas:\n           Presents LATE \u2014 no biliary obstruction;\n           weight loss, epigastric pain radiating to back\n           (relieved by leaning forward \u2014 characteristic),\n           new-onset diabetes in elderly.\n           Usually unresectable at diagnosis.\n         Tumour marker: CA 19-9 (not specific, not for screening;\n           used for monitoring treatment response).\n         Double duct sign: simultaneous dilation of CBD +\n           pancreatic duct on MRCP\/ERCP = head carcinoma.\n         Answer: Head \u2014 painless jaundice, Courvoisier's sign,\n                 double duct sign; Body\/tail \u2014 pain + weight loss,\n                 late presentation; CA 19-9 monitoring only.\n\n     Q5  PANCREATIC ENDOCRINE TUMOURS \u2014 INSULINOMA & ZES (Hard)\n         Insulinoma:\n           Most common pancreatic endocrine tumour.\n           Whipple's triad: (1) symptoms of hypoglycaemia\n             during fasting, (2) blood glucose <45 mg\/dL,\n             (3) relief with glucose administration.\n           Investigation: 72-hour supervised fast (gold\n             standard) \u2014 hypoglycaemia + elevated insulin +\n             elevated C-peptide (excludes factitious).\n           C-peptide elevated = endogenous insulin; C-peptide\n             suppressed = exogenous insulin injection (factitious).\n           Localisation: CT\/MRI + endoscopic USS.\n           Treatment: surgical resection (>90% benign).\n           Medical bridge: diazoxide (inhibits insulin release).\n         Zollinger-Ellison Syndrome (ZES):\n           Gastrinoma (non-beta islet cell tumour) \u2014 usually\n             in gastrinoma triangle (pancreatic head \/ duodenum).\n           Excess gastrin \u2192 massive acid hypersecretion \u2192\n             multiple, refractory, atypically located peptic\n             ulcers (distal duodenum, jejunum).\n           Diarrhoea, steatorrhoea (acid inactivates lipase).\n           Diagnosis: fasting serum gastrin >1000 pg\/mL or\n             secretin stimulation test (paradoxical \u2191 in gastrin).\n           Associated with MEN-1 (check PTH, prolactin).\n           Treatment: high-dose PPI + surgical resection.\n         Answer: Insulinoma \u2014 Whipple's triad, 72-hr fast,\n                 C-peptide distinguishes endogenous from\n                 exogenous; ZES \u2014 high gastrin, secretin test,\n                 MEN-1 association, high-dose PPI.\n     ================================================================ *\/\n\n  var QS = [\n\n    \/* ---- Q1 : Acute Pancreatitis ---- *\/\n    {\n      id:      1,\n      diff:    'Easy',\n      tag:     'Pancreas &mdash; Acute Pancreatitis',\n      stem:    'A <strong>45-year-old man<\/strong> presents with <strong>sudden-onset severe epigastric pain radiating to the back<\/strong>, nausea, and vomiting after a heavy meal. Serum amylase is 1,200 IU\/L. On admission his WBC is 18,000\/mm\u00b3, blood glucose is 220 mg\/dL, serum LDH is 400 IU\/L, and AST is 280 IU\/L. At 48 hours, his haematocrit has fallen by 12% and serum calcium is 7.4 mg\/dL. Which statement correctly identifies the <strong>most common overall cause<\/strong> of acute pancreatitis, the significance of his Ranson score, and the cornerstone of early management?',\n      correct: 'Gallstones are the most common overall cause; this patient meets \u22655 Ranson criteria indicating severe disease with significant mortality risk; aggressive IV fluid resuscitation is the cornerstone of early management',\n      opts: [\n        'Gallstones are the most common overall cause; this patient meets \u22655 Ranson criteria indicating severe disease with significant mortality risk; aggressive IV fluid resuscitation is the cornerstone of early management',\n        'Alcohol is the most common overall cause of acute pancreatitis worldwide; Ranson score \u22653 indicates mild disease requiring only oral analgesia and early feeding; prophylactic antibiotics are the cornerstone of management',\n        'Hypertriglyceridaemia is the most common cause; a Ranson score of 5 confirms infected pancreatic necrosis requiring immediate surgical debridement',\n        'Gallstones are the most common cause; serum amylase >1000 IU\/L alone is sufficient to grade severity as severe; early ERCP within 6 hours is mandatory in all cases of acute pancreatitis'\n      ],\n      exp: '<strong>Causes of acute pancreatitis<\/strong> in order of frequency: <strong>Gallstones<\/strong> (#1 overall), <strong>alcohol<\/strong> (#2 overall; #1 in men in India), hypertriglyceridaemia, ERCP, drugs (azathioprine, thiazides, valproate, steroids, tetracycline), hypercalcaemia, scorpion sting (<em>Mesobuthus tamulus<\/em> \u2014 India-specific, high yield for CMS), trauma, mumps, idiopathic. Mnemonic: <strong>GET SMASHED<\/strong>. <strong>Ranson\\'s criteria<\/strong> (non-gallstone): 5 on admission (Age &gt;55, WBC &gt;16,000, Glucose &gt;200, LDH &gt;350, AST &gt;250) + 6 at 48 hours (Hct fall &gt;10%, BUN rise &gt;5, Ca\u00b2\u207a &lt;8, PaO\u2082 &lt;60, Base deficit &gt;4, Fluid sequestration &gt;6 L). Score \u22653 = severe; each criterion adds ~1% mortality; score \u22655 carries ~40% mortality. This patient meets at least 5. <strong>Management cornerstone:<\/strong> <strong>aggressive IV fluid resuscitation<\/strong> with Ringer\\'s lactate (preferred over normal saline) \u2014 reduces pancreatic necrosis and organ failure. NBM initially; early enteral nutrition (nasojejunal) preferred over TPN once tolerated.',\n      extra: '<strong>ERCP<\/strong> is <em>not<\/em> indicated in all acute pancreatitis \u2014 only when gallstone pancreatitis is complicated by <strong>cholangitis or persistent biliary obstruction<\/strong> (within 24\u201372 hours). Routine early ERCP in mild gallstone pancreatitis does not improve outcomes. <strong>Antibiotics<\/strong> are <em>not<\/em> indicated prophylactically in sterile necrosis \u2014 only when <strong>infected necrosis<\/strong> is confirmed or strongly suspected (fever persisting &gt;7\u201310 days, gas in pancreatic bed on CT). Carbapenem (meropenem\/imipenem) is preferred as it penetrates pancreatic tissue. The 2012 revised Atlanta classification grades severity as mild (no organ failure), moderately severe (transient &lt;48 hr organ failure or local complications), and severe (persistent &gt;48 hr organ failure) \u2014 this supersedes the original Atlanta criteria and is the current exam standard.'\n    },\n\n    \/* ---- Q2 : Complications ---- *\/\n    {\n      id:      2,\n      diff:    'Medium',\n      tag:     'Pancreas &mdash; Complications of Acute Pancreatitis',\n      stem:    'A <strong>38-year-old man<\/strong> with alcoholic pancreatitis is re-admitted <strong>six weeks after his initial episode<\/strong> with recurrent epigastric pain and early satiety. CT abdomen shows a <strong>well-defined, thick-walled, fluid-filled collection<\/strong> in the lesser sac measuring 8 cm, with no solid debris. On examination he has <strong>bluish discolouration around the umbilicus<\/strong>. Which statement correctly identifies the CT finding, what the periumbilical sign indicates, and the mechanism of the metabolic disturbance most commonly seen in severe acute pancreatitis?',\n      correct: 'Pancreatic pseudocyst (fluid collection with fibrous wall, no epithelial lining, >4 weeks post-pancreatitis); Cullen\\'s sign indicates retroperitoneal haemorrhage tracking to the periumbilical region; hypocalcaemia occurs due to saponification \u2014 calcium binds free fatty acids released by pancreatic lipase',\n      opts: [\n        'Pancreatic pseudocyst (fluid collection with fibrous wall, no epithelial lining, >4 weeks post-pancreatitis); Cullen\\'s sign indicates retroperitoneal haemorrhage tracking to the periumbilical region; hypocalcaemia occurs due to saponification \u2014 calcium binds free fatty acids released by pancreatic lipase',\n        'Walled-off necrosis (contains solid necrotic debris, requires necrosectomy immediately); Cullen\\'s sign indicates splenic vein thrombosis; hypocalcaemia occurs due to hypoalbuminaemia causing reduced calcium-binding protein',\n        'Pancreatic abscess (infected fluid collection requiring urgent surgical drainage); Grey Turner\\'s sign indicates retroperitoneal haemorrhage tracking to the flank; hypocalcaemia is caused by pancreatitis-induced primary hypoparathyroidism',\n        'Acute peripancreatic fluid collection (no wall, resolves spontaneously, no intervention needed); Cullen\\'s sign is specific to biliary peritonitis from CBD perforation; hypocalcaemia is caused by excess calcitonin release from pancreatic delta cells'\n      ],\n      exp: '<strong>Pancreatic pseudocyst<\/strong> \u2014 defined by three features: (1) <em>fluid collection<\/em> (no solid debris \u2014 distinguishes it from walled-off necrosis); (2) <em>non-epithelialised fibrous wall<\/em> (not a true cyst); (3) develops <em>&gt;4 weeks<\/em> after acute pancreatitis or exacerbation of chronic pancreatitis. On CT: round or oval, homogeneous fluid density, thick enhancing wall, usually in lesser sac. Most (40\u201350%) resolve spontaneously. Indications for drainage: symptomatic (pain, gastric outlet obstruction), enlarging, infected, or complicated. <strong>Endoscopic cystogastrostomy<\/strong> is the preferred drainage route. <strong>Cullen\\'s sign:<\/strong> periumbilical bruising \u2014 retroperitoneal haemorrhage tracking along the falciform ligament. <strong>Grey Turner\\'s sign:<\/strong> flank bruising \u2014 haemorrhage tracking along the retroperitoneal planes to the flank. Both are signs of <strong>haemorrhagic pancreatitis<\/strong> and carry a very poor prognosis. <strong>Hypocalcaemia mechanism:<\/strong> <em>saponification<\/em> \u2014 pancreatic lipase released into the retroperitoneum hydrolyses fat into fatty acids, which bind calcium to form insoluble calcium soaps (calcium saponification), dramatically lowering serum calcium.',\n      extra: '<strong>Differentiating local complications (2012 Atlanta revised):<\/strong><br>\u2022 <em>Acute peripancreatic fluid collection (APFC)<\/em>: &lt;4 weeks, no wall, in or around pancreas \u2014 most resolve spontaneously.<br>\u2022 <em>Pancreatic pseudocyst<\/em>: &gt;4 weeks, well-defined wall, fluid only (no solid debris).<br>\u2022 <em>Acute necrotic collection (ANC)<\/em>: &lt;4 weeks, contains necrotic tissue, no defined wall.<br>\u2022 <em>Walled-off necrosis (WON)<\/em>: &gt;4 weeks, well-defined wall, <em>contains solid necrotic debris<\/em> \u2014 this is the key distinction from pseudocyst.<br>Infected WON requires <strong>step-up approach<\/strong>: antibiotics \u2192 percutaneous drainage \u2192 endoscopic\/video-assisted retroperitoneal debridement (VARD) \u2192 open necrosectomy as last resort. Minimally invasive first is now the standard of care \u2014 open surgery has higher morbidity.'\n    },\n\n    \/* ---- Q3 : Chronic Pancreatitis ---- *\/\n    {\n      id:      3,\n      diff:    'Medium',\n      tag:     'Pancreas &mdash; Chronic Pancreatitis',\n      stem:    'A <strong>22-year-old man<\/strong> from rural Odisha presents with <strong>recurrent abdominal pain since childhood, significant weight loss, and loose, greasy stools<\/strong>. He does not drink alcohol. Plain X-ray abdomen shows <strong>large, dense, intraductal calcifications<\/strong> throughout the pancreas. Blood glucose is 18 mmol\/L and he has never had diabetic ketoacidosis despite poor control. Which form of chronic pancreatitis does this represent, what is the mechanism of his steatorrhoea, and what is the appropriate enzyme replacement?',\n      correct: 'Tropical (fibrocalculous) pancreatitis \u2014 FCPD; steatorrhoea results from exocrine insufficiency (lipase deficiency) causing fat malabsorption; pancreatic enzyme replacement therapy (PERT) with high-lipase pancreatin taken with meals',\n      opts: [\n        'Tropical (fibrocalculous) pancreatitis \u2014 FCPD; steatorrhoea results from exocrine insufficiency (lipase deficiency) causing fat malabsorption; pancreatic enzyme replacement therapy (PERT) with high-lipase pancreatin taken with meals',\n        'Alcoholic chronic pancreatitis presenting in a young patient; steatorrhoea results from bile acid deficiency due to associated cholestatic liver disease; ursodeoxycholic acid corrects fat malabsorption',\n        'Autoimmune pancreatitis type 1 (IgG4-related); steatorrhoea is caused by duodenal mucosal atrophy impairing absorption; first-line treatment is corticosteroids, not enzyme replacement',\n        'Hereditary pancreatitis (PRSS1 mutation); steatorrhoea results from endocrine insufficiency causing glucagon deficiency and reduced intestinal motility; insulin therapy corrects both diabetes and steatorrhoea'\n      ],\n      exp: '<strong>Tropical pancreatitis<\/strong> (Fibrocalculous Pancreatic Diabetes \u2014 FCPD) is a form of chronic pancreatitis unique to tropical countries \u2014 India, Bangladesh, parts of Africa and Southeast Asia. Key features: young patient (teens\u2013twenties), non-alcoholic, history of malnutrition, <strong>large intraductal calcifications<\/strong> (often visible on plain X-ray \u2014 unlike alcoholic CP where calcifications are smaller and less dramatic), and a characteristic <strong>ketosis-resistant diabetes mellitus<\/strong>. The ketosis resistance is explained by partial preservation of glucagon-secreting alpha cells even as beta cells are destroyed \u2014 glucagon counters ketone formation. <strong>Steatorrhoea mechanism:<\/strong> progressive destruction of pancreatic acinar cells \u2192 exocrine insufficiency \u2192 <em>lipase deficiency<\/em> \u2192 fat malabsorption \u2192 fatty, greasy, foul-smelling stools (steatorrhoea). Faecal elastase-1 is a useful non-invasive test for exocrine insufficiency (low = insufficiency). <strong>PERT (Pancreatic Enzyme Replacement Therapy):<\/strong> high-lipase pancreatin (e.g. Creon) taken <em>with meals<\/em> (not before or after) \u2014 corrects fat malabsorption.',\n      extra: '<strong>FCPD \u2014 India-specific high yield:<\/strong> FCPD is a uniquely Indian entity that is repeatedly tested in CMS and NEET-PG. The combination of (1) young non-alcoholic patient, (2) tropical background, (3) large pancreatic calculi on plain X-ray, and (4) ketosis-resistant brittle diabetes is pathognomonic. The SPINK1 mutation (serine protease inhibitor Kazal type 1) is found in a significant proportion of Indian tropical pancreatitis cases. <strong>Puestow procedure<\/strong> (lateral pancreaticojejunostomy) is indicated when the main pancreatic duct is dilated (&gt;7 mm) with stricturing \u2014 it decompresses the duct and provides durable pain relief in carefully selected patients. <strong>Autoimmune pancreatitis (AIP):<\/strong> a differential to remember \u2014 presents with obstructive jaundice, diffuse pancreatic enlargement (\"sausage pancreas\" on CT), elevated IgG4, and dramatic response to steroids. It can mimic pancreatic carcinoma \u2014 the steroid response test helps distinguish them.'\n    },\n\n    \/* ---- Q4 : Carcinoma of Pancreas ---- *\/\n    {\n      id:      4,\n      diff:    'Hard',\n      tag:     'Pancreas &mdash; Carcinoma of Pancreas',\n      stem:    'A <strong>65-year-old man<\/strong> presents with a <strong>6-week history of progressive, painless jaundice<\/strong> with dark urine and pale stools and 8 kg weight loss. On examination, a <strong>non-tender, palpable gallbladder<\/strong> is felt in the right hypochondrium. MRCP shows <strong>simultaneous dilation of the common bile duct and the main pancreatic duct<\/strong>. CA 19-9 is markedly elevated. Which eponymous law explains the gallbladder finding, what does the MRCP pattern indicate, and which surgical procedure offers the only chance of cure?',\n      correct: 'Courvoisier\\'s law: a palpable, non-tender gallbladder with jaundice suggests malignant obstruction rather than gallstones (gallstone disease causes a fibrotic, non-distensible gallbladder); double duct sign indicates carcinoma of the head of pancreas; Whipple\\'s operation (pancreaticoduodenectomy) is the only potentially curative procedure',\n      opts: [\n        'Courvoisier\\'s law: a palpable, non-tender gallbladder with jaundice suggests malignant obstruction rather than gallstones (gallstone disease causes a fibrotic, non-distensible gallbladder); double duct sign indicates carcinoma of the head of pancreas; Whipple\\'s operation (pancreaticoduodenectomy) is the only potentially curative procedure',\n        'Murphy\\'s sign: a palpable tender gallbladder with jaundice confirms acute cholecystitis with CBD stone; double duct sign on MRCP indicates primary sclerosing cholangitis; biliary drainage alone is curative for benign biliary strictures',\n        'Courvoisier\\'s law: a palpable non-tender gallbladder confirms choledocholithiasis causing gallbladder distension; isolated CBD dilation without pancreatic duct dilation is the hallmark of pancreatic head carcinoma; distal pancreatectomy is the curative operation',\n        'Boas\\'s sign: referred pain to the right shoulder with palpable gallbladder confirms carcinoma of the body of pancreas; the double duct sign indicates cholangiocarcinoma of the hilum; total pancreatectomy is required for cure'\n      ],\n      exp: '<strong>Courvoisier\\'s law:<\/strong> a palpable, non-tender gallbladder in a jaundiced patient is <em>unlikely<\/em> to be due to gallstones, and is <em>likely<\/em> due to malignant obstruction (carcinoma of the head of pancreas, ampullary carcinoma, cholangiocarcinoma). Rationale: chronic inflammation from gallstones causes the gallbladder wall to fibrosis and contract \u2014 it cannot distend. Malignant obstruction in a previously normal gallbladder allows progressive distension. <strong>Double duct sign:<\/strong> simultaneous dilation of the <em>common bile duct (CBD)<\/em> and the <em>main pancreatic duct (Wirsung)<\/em> on MRCP or ERCP \u2014 almost pathognomonic of carcinoma of the <strong>head of pancreas<\/strong> (the tumour obstructs both ducts as they converge at the ampulla of Vater). <strong>CA 19-9:<\/strong> tumour marker \u2014 not for screening (low sensitivity\/specificity); used to monitor treatment response and recurrence. <strong>Whipple\\'s operation<\/strong> (pancreaticoduodenectomy): resects the pancreatic head, duodenum, distal CBD, gallbladder, and distal stomach \u2014 the only potentially curative procedure. Only ~20% of patients are resectable at diagnosis.',\n      extra: '<strong>Head vs Body\/Tail \u2014 the clinical contrast:<\/strong> Carcinoma of the <em>head<\/em> presents relatively early with obstructive jaundice \u2014 paradoxically giving a better chance of diagnosis before metastasis. Carcinoma of the <em>body and tail<\/em> is clinically silent until late \u2014 no biliary obstruction, only weight loss, back pain (relieved by leaning forward \u2014 characteristic of retroperitoneal invasion), and new-onset diabetes mellitus in an elderly patient without prior risk factors. By the time body\/tail tumours are diagnosed, most are unresectable. <strong>New-onset diabetes in a patient over 60 with weight loss and vague back pain = exclude pancreatic carcinoma.<\/strong> This presentation pattern is repeatedly tested in CMS. Palliative options: biliary stenting (ERCP or percutaneous), gastric bypass for duodenal obstruction, and gemcitabine-based chemotherapy.'\n    },\n\n    \/* ---- Q5 : Endocrine Tumours ---- *\/\n    {\n      id:      5,\n      diff:    'Hard',\n      tag:     'Pancreas &mdash; Endocrine Tumours',\n      stem:    'A <strong>35-year-old woman<\/strong> presents with <strong>episodic sweating, palpitations, and confusion<\/strong> that occur in the early morning before breakfast and are relieved by eating. Her fasting blood glucose during one episode is 38 mg\/dL and her serum insulin is markedly elevated. Her <strong>C-peptide is also elevated<\/strong>. CT shows a 1.5 cm lesion in the pancreatic tail. Her colleague, a <strong>42-year-old man<\/strong>, presents separately with <strong>multiple duodenal ulcers refractory to standard PPI doses<\/strong>, severe diarrhoea, and a fasting serum gastrin of 1,400 pg\/mL. Which eponymous triad confirms the first diagnosis, what does the elevated C-peptide prove, and what additional syndrome must be excluded in the second patient?',\n      correct: 'Whipple\\'s triad (fasting hypoglycaemia + blood glucose <45 mg\/dL + relief with glucose) confirms insulinoma; elevated C-peptide confirms endogenous insulin excess (not factitious hypoglycaemia from exogenous insulin injection); MEN-1 syndrome must be excluded in Zollinger-Ellison syndrome (gastrinoma)',\n      opts: [\n        'Whipple\\'s triad (fasting hypoglycaemia + blood glucose <45 mg\/dL + relief with glucose) confirms insulinoma; elevated C-peptide confirms endogenous insulin excess (not factitious hypoglycaemia from exogenous insulin injection); MEN-1 syndrome must be excluded in Zollinger-Ellison syndrome (gastrinoma)',\n        'Whipple\\'s triad confirms glucagonoma; suppressed C-peptide confirms that endogenous insulin is being appropriately reduced in response to hypoglycaemia; MEN-2 must be excluded in gastrinoma',\n        'Whipple\\'s triad confirms VIPoma (Verner-Morrison syndrome); elevated C-peptide is a non-specific finding seen in any form of hypoglycaemia; carcinoid syndrome must be excluded given the diarrhoea in the second patient',\n        'Courvoisier\\'s triad confirms insulinoma; C-peptide elevation confirms factitious hypoglycaemia from surreptitious insulin injection; MEN-1 is not associated with gastrinoma and need not be excluded'\n      ],\n      exp: '<strong>Insulinoma<\/strong> is the most common pancreatic endocrine tumour (&gt;90% benign). <strong>Whipple\\'s triad:<\/strong> (1) symptoms of hypoglycaemia during fasting or exercise, (2) documented low blood glucose (&lt;45 mg\/dL \/ 2.5 mmol\/L), (3) relief of symptoms with glucose administration. Gold standard investigation: <strong>72-hour supervised fast<\/strong> \u2014 hypoglycaemia + inappropriately elevated insulin + elevated C-peptide. <strong>C-peptide:<\/strong> pro-insulin is cleaved into insulin + C-peptide in equimolar quantities by the beta cell. Exogenous insulin contains no C-peptide. Therefore: elevated C-peptide = <em>endogenous<\/em> insulin excess = insulinoma (or sulphonylurea abuse). Suppressed C-peptide + elevated insulin = <em>exogenous<\/em> insulin injection (factitious hypoglycaemia). Treatment: surgical resection; diazoxide (inhibits insulin secretion) as a bridge. <strong>Zollinger-Ellison syndrome (ZES):<\/strong> gastrinoma causing massive gastric acid hypersecretion \u2192 multiple, large, atypically located (distal duodenum\/jejunum), refractory ulcers + diarrhoea + steatorrhoea (acid inactivates lipase). Fasting serum gastrin &gt;1000 pg\/mL is diagnostic; secretin stimulation test (paradoxical rise in gastrin) confirms.',\n      extra: '<strong>MEN-1 (Multiple Endocrine Neoplasia type 1)<\/strong> \u2014 the 3 Ps: Parathyroid (hyperparathyroidism \u2014 most common, &gt;90%), Pituitary (prolactinoma most common), Pancreas (gastrinoma most common pancreatic tumour in MEN-1, followed by insulinoma). <strong>All patients with ZES must be screened for MEN-1<\/strong> by checking serum calcium and PTH (hyperparathyroidism is often the first manifestation). MEN-1 is caused by mutations in the <em>MEN1<\/em> gene (menin \u2014 chromosome 11). <strong>MEN-2A:<\/strong> medullary thyroid carcinoma + phaeochromocytoma + hyperparathyroidism (RET mutation). <strong>MEN-2B:<\/strong> MTC + phaeochromocytoma + mucosal neuromas + marfanoid habitus. These MEN associations are reliable high-yield one-liners for both NEET-PG and CMS.'\n    }\n\n  ];\n  \/* ================================================================\n     END OF CONTENT \u2014 engine logic below, do not edit\n     ================================================================ *\/\n\n  var answers  = {};\n  var answered = 0;\n  var shuffled = {};\n  var done     = false;\n\n  function byId(id) { return document.getElementById(id); }\n  function gid(sfx) { return byId(NS + '-' + sfx); }\n\n  function shuffleArr(arr) {\n    var a = arr.slice(), i, j, t;\n    for (i = a.length - 1; i > 0; i--) {\n      j = Math.floor(Math.random() * (i + 1));\n      t = a[i]; a[i] = a[j]; a[j] = t;\n    }\n    return a;\n  }\n\n  function countVal(val) {\n    var k, n = 0;\n    for (k in answers) {\n      if (answers.hasOwnProperty(k) && answers[k] === val) n++;\n    }\n    return n;\n  }\n\n  function buildPips() {\n    var cont = gid('pips'), i, q, wl, wp, line, pip;\n    if (!cont) return;\n    cont.innerHTML = '';\n    for (i = 0; i < QS.length; i++) {\n      q = QS[i];\n      if (i > 0) {\n        wl = document.createElement('div'); wl.className = 'mr-pip-wrap';\n        line = document.createElement('div'); line.className = 'mr-pip-line';\n        line.id = NS + '-pl' + q.id;\n        wl.appendChild(line); cont.appendChild(wl);\n      }\n      wp  = document.createElement('div'); wp.className = 'mr-pip-wrap';\n      pip = document.createElement('div'); pip.className = 'mr-pip';\n      pip.id = NS + '-pip' + q.id;\n      pip.textContent = String(q.id);\n      wp.appendChild(pip); cont.appendChild(wp);\n    }\n  }\n\n  function build() {\n    var cont, i, q, opts, card, top, nd, meta, tagRow, tg, dl,\n        st, rule, od, ed, lb, tx, ep, epl, ept, j, oe, ls, ts;\n    cont = gid('cases');\n    if (!cont) return;\n    cont.innerHTML = '';\n    answers = {}; answered = 0; shuffled = {}; done = false;\n    if (gid('score')) gid('score').style.display = 'none';\n    buildPips();\n    for (i = 0; i < QS.length; i++) {\n      q    = QS[i];\n      opts = shuffleArr(q.opts);\n      shuffled[q.id] = opts;\n\n      card = document.createElement('div'); card.className = 'mr-case';\n      top  = document.createElement('div'); top.className  = 'mr-case-top';\n      nd   = document.createElement('div'); nd.className   = 'mr-num';\n      nd.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n      meta = document.createElement('div'); meta.className = 'mr-meta';\n\n      tagRow = document.createElement('div'); tagRow.className = 'mr-tag-row';\n      tg = document.createElement('div'); tg.className = 'mr-tag'; tg.innerHTML = q.tag;\n      dl = document.createElement('div'); dl.className = 'mr-diff'; dl.textContent = q.diff;\n      tagRow.appendChild(tg); tagRow.appendChild(dl);\n\n      st = document.createElement('div'); st.className = 'mr-stem'; st.innerHTML = q.stem;\n      meta.appendChild(tagRow); meta.appendChild(st);\n      top.appendChild(nd); top.appendChild(meta);\n      card.appendChild(top);\n\n      rule = document.createElement('div'); rule.className = 'mr-rule';\n      card.appendChild(rule);\n\n      od = document.createElement('div'); od.className = 'mr-opts';\n      for (j = 0; j < opts.length; j++) {\n        oe = document.createElement('div'); oe.className = 'mr-opt';\n        oe.id = NS + '-o' + q.id + '-' + j;\n        oe.setAttribute('role', 'button'); oe.setAttribute('tabindex', '0');\n        ls = document.createElement('span'); ls.className = 'mr-ltr'; ls.textContent = LTRS[j];\n        ts = document.createElement('span'); ts.className = 'mr-opt-text'; ts.innerHTML = opts[j];\n        oe.appendChild(ls); oe.appendChild(ts); od.appendChild(oe);\n        (function (qid, oi) {\n          oe.addEventListener('click', function () { pick(qid, oi); });\n        }(q.id, j));\n      }\n      card.appendChild(od);\n\n      ed  = document.createElement('div'); ed.className = 'mr-exp'; ed.id = NS + '-exp' + q.id;\n      lb  = document.createElement('div'); lb.className = 'mr-exp-lbl'; lb.textContent = 'Debrief';\n      tx  = document.createElement('div'); tx.className = 'mr-exp-text'; tx.innerHTML = q.exp;\n      ed.appendChild(lb); ed.appendChild(tx);\n\n      if (q.extra) {\n        ep  = document.createElement('div'); ep.className = 'mr-exp-extra';\n        epl = document.createElement('span'); epl.className = 'mr-exp-extra-lbl'; epl.textContent = 'Extra Points';\n        ept = document.createElement('div'); ept.innerHTML = q.extra;\n        ep.appendChild(epl); ep.appendChild(ept);\n        ed.appendChild(ep);\n      }\n\n      card.appendChild(ed);\n      cont.appendChild(card);\n    }\n  }\n\n  function pick(qid, oi) {\n    var q, opts, i, el, ok;\n    if (answers[qid] !== undefined || done) return;\n    q = null;\n    for (i = 0; i < QS.length; i++) { if (QS[i].id === qid) { q = QS[i]; break; } }\n    if (!q) return;\n    opts = shuffled[qid];\n    ok   = (opts[oi] === q.correct);\n    answers[qid] = ok ? 'c' : 'w';\n    answered++;\n    for (i = 0; i < opts.length; i++) {\n      el = byId(NS + '-o' + qid + '-' + i);\n      if (!el) continue;\n      el.className = opts[i] === q.correct ? 'mr-opt correct locked'\n                   : i === oi              ? 'mr-opt wrong locked'\n                                           : 'mr-opt dimmed locked';\n    }\n    var ex = byId(NS + '-exp' + qid); if (ex) ex.style.display = 'block';\n    var pp = byId(NS + '-pip' + qid); if (pp) pp.className = 'mr-pip ' + (ok ? 'correct' : 'wrong');\n    if (qid > 1) { var pl = gid('pl' + qid); if (pl) pl.className = 'mr-pip-line done'; }\n  }\n\n  function showScore() {\n    var c, w, s, net, pct, disp, vlist, vi, sc;\n    if (done) return;\n    done = true;\n    c   = countVal('c'); w = countVal('w'); s = TOTAL - answered;\n    net  = c * 4 - w;\n    pct  = Math.max(0, Math.round((net \/ MAX) * 100));\n    disp = Math.min(100, Math.max(0, pct));\n    var rg = gid('ring');\n    if (rg) rg.style.background = 'conic-gradient(#1A6B5A ' + disp + '%, #D8E8E5 0%)';\n    var pe = gid('pct'); if (pe) pe.textContent = pct + '%';\n    var ne = gid('net'); if (ne) ne.textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n    vlist = [\n      [5, 'Flawless. The pancreas gave you nothing to worry about.'],\n      [4, 'Strong round \\u2014 one clinical pattern worth a second look before exam day.'],\n      [3, 'Solid base \\u2014 the Extra Points carry the eponyms and edge cases that tip marks.'],\n      [2, 'Halfway there \\u2014 Ranson\\'s criteria and the endocrine tumours are the places to consolidate.'],\n      [0, 'The pancreas rewards methodical revision. The debrief panels have everything you need.']\n    ];\n    var ve = gid('verdict');\n    if (ve) {\n      ve.textContent = vlist[4][1];\n      for (vi = 0; vi < vlist.length; vi++) {\n        if (c >= vlist[vi][0]) { ve.textContent = vlist[vi][1]; break; }\n      }\n    }\n    var cc = gid('ct-c'); if (cc) cc.textContent = '\\u2705 ' + c + ' Correct';\n    var cw = gid('ct-w'); if (cw) cw.textContent = '\\u274C ' + w + ' Wrong';\n    var cs = gid('ct-s'); if (cs) cs.textContent = '\\u23ED ' + s + ' Skipped';\n    sc = gid('score');\n    if (sc) { sc.style.display = 'block'; sc.scrollIntoView({ behavior: 'smooth', block: 'center' }); }\n  }\n\n  function initObserver() {\n    var sn = gid('sentinel'), bar = gid('progress');\n    if (!sn || !bar || !window.IntersectionObserver) return;\n    new IntersectionObserver(function (en) {\n      bar.className = en[0].isIntersecting ? 'mr-progress' : 'mr-progress visible';\n    }, { threshold: 0 }).observe(sn);\n  }\n\n  function init() {\n    var sb = gid('submit'), rb = gid('retry');\n    if (!sb || !rb) return;\n    sb.addEventListener('click', showScore);\n    rb.addEventListener('click', function () { build(); window.scrollTo(0, 0); });\n    initObserver();\n    build();\n  }\n\n  function tryInit(n) {\n    if (document.getElementById('git05-cases')) {\n      init();\n    } else if (n < 40) {\n      setTimeout(function () { tryInit(n + 1); }, 50);\n    }\n  }\n\n  tryInit(0);\n\n}());\n<\/script>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds &middot; GIT Series Pancreatic DiseasesGastroenterology Five high-yield clinical cases &middot; +4 \/ &minus;1 scoring &middot; NEET-PG and UPSC CMS 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635; New Round<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[18,76,74,24],"tags":[],"class_list":["post-36922","post","type-post","status-publish","format-standard","hentry","category-cms","category-git","category-morning-rounds","category-neet-pg"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pancreatic Diseases - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pancreatic Diseases - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds &middot; GIT Series Pancreatic DiseasesGastroenterology Five high-yield clinical cases &middot; +4 \/ &minus;1 scoring &middot; NEET-PG and UPSC CMS 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635; New Round\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-03T14:30:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-03T14:31:36+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Pancreatic Diseases\",\"datePublished\":\"2026-06-03T14:30:57+00:00\",\"dateModified\":\"2026-06-03T14:31:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/\"},\"wordCount\":37,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"articleSection\":[\"CMS\",\"GIT\",\"Morning Rounds\",\"NEET PG\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/\",\"name\":\"Pancreatic Diseases - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-06-03T14:30:57+00:00\",\"dateModified\":\"2026-06-03T14:31:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/pancreatic-diseases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pancreatic Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pancreatic Diseases - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/","og_locale":"en_US","og_type":"article","og_title":"Pancreatic Diseases - atsixty","og_description":"Morning Rounds &middot; GIT Series Pancreatic DiseasesGastroenterology Five high-yield clinical cases &middot; +4 \/ &minus;1 scoring &middot; NEET-PG and UPSC CMS 5 Cases +4 \/ &minus;1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief &#8635; New Round","og_url":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/","og_site_name":"atsixty","article_published_time":"2026-06-03T14:30:57+00:00","article_modified_time":"2026-06-03T14:31:36+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Pancreatic Diseases","datePublished":"2026-06-03T14:30:57+00:00","dateModified":"2026-06-03T14:31:36+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/"},"wordCount":37,"commentCount":0,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"articleSection":["CMS","GIT","Morning Rounds","NEET PG"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/","url":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/","name":"Pancreatic Diseases - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-06-03T14:30:57+00:00","dateModified":"2026-06-03T14:31:36+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/cms\/pancreatic-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Pancreatic Diseases"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/36922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=36922"}],"version-history":[{"count":1,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/36922\/revisions"}],"predecessor-version":[{"id":36923,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/36922\/revisions\/36923"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=36922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=36922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=36922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}